FDA Import Refusal 1FX-1166687-3/10002/1 — Cipla Ltd.
The FDA refused shipment 1FX-1166687-3/10002/1 from Cipla Ltd. (India) on Aug 14, 2026. The refused product falls under Drugs and Biologics — TAMSULOSIN HCL (REGULATOR). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 14, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 65PDY03 TAMSULOSIN HCL (REGULATOR)
- Charges
- 75